The ASM presented recommendations to the Centers for Medicare & Medicaid Services at its annual public meeting on payment levels for new tests to be included in the 2016 Clinical Laboratory Fee Schedule.
The ASM sent comments on the 21st Centurey Cures Initiative to the House Committee on Energy and Commerce.
The ASM submitted comments in response to the Office of Science and Technology and Policy's request for comment on the impact that the Select Agent Regulations have had on science, technology, and national security, and on the benefits, costs, and limitations of the regulations.
April 21, 2015 - Energy & Environment Provisions in the America COMPETES Reauthorization Act of 2016
The ASM sent a letter to members of the House Committee on Science, Space and Technology about provisions in the America Competes Reauthorization Act of 2016, H.R. 1806.
The ASM submitted comments to the Centers for Disease Control on the Biennial Review of the Select Agent Regulations.